Published in Proc Soc Exp Biol Med on December 01, 1962
Global distribution of novel rhinovirus genotype. Emerg Infect Dis (2008) 2.03
STUDIES WITH RHINOVIRUSES IN VOLUNTEERS: PRODUCTION OF ILLNESS, EFFECT OF NATURALLLY ACQUIRED ANTIBODY, AND DEMONSTRATION OF A PROTECTIVE EFFECT NOT ASSOCIATED WITH SERUM ANTIBODY. J Clin Invest (1964) 1.85
Rhinoviruses. Yale J Biol Med (1975) 1.66
Immune electron microscopy of rhinoviruses. J Virol (1972) 1.64
New member of the herpesvirus group isolated from wild cottontail rabbits. Infect Immun (1971) 1.32
Use of zonal ultracentrifuge systems for biophysical studies of rhinoviruses. J Virol (1968) 1.32
Infectivity and sedimentation of rhinovirus ribonucleic acid. J Virol (1971) 1.29
2. Etiology. Public Health Rep (1964) 1.24
A new influenza virus infection in turkeys. I. Isolation and characterization of virus 6213. Can Vet J (1968) 1.22
Enhancement of the infectivity of rhinovirus ribonucleic acid by diethylaminoethyl dextran. Appl Microbiol (1969) 1.19
Physiochemical characterization of a neonatal calf diarrhea virus. Can J Comp Med (1973) 1.14
Adsorption of viruses to charge-modified silica. Appl Environ Microbiol (1985) 1.14
A comparative virological study of children in hospital with respiratory and diarrhoeal illnesses. J Hyg (Lond) (1967) 1.12
Density of infectious virus and complement-fixing antigens of two rhinovirus strains. J Bacteriol (1966) 1.10
SOME PHYSICO-CHEMICAL PROPERTIES OF RHINOVIRUSES. Br J Exp Pathol (1964) 1.08
THE SPECIFICITY OF THE ANTIBODY RESPONSES OF HUMAN VOLUNTEERS TO CERTAIN RESPIRATORY VIRUSES. J Hyg (Lond) (1964) 0.97
VIRUSES FROM THE COMMON COLD. A SURVEY IN ROYAL AIR FORCE RECRUITS ON ARRIVAL FROM CIVILIAN LIFE. J Hyg (Lond) (1963) 0.90
The rhinoviruses of man. Calif Med (1970) 0.83
RHINOVIRUSES AND RESPIRATORY DISEASE. Bacteriol Rev (1964) 0.81
THE ISOLATION OF AN UNCLASSIFIED VIRUS FROM AN OUTBREAK OF INFANTILE DIARRHOEA. J Hyg (Lond) (1964) 0.80
The Properties and Classification of Bovine Viral Diarrhea Virus. Can J Comp Med Vet Sci (1964) 0.79
SUBCLASSIFICATION OF PICORNAVIRUSES. Bacteriol Rev (1965) 0.79
Clinical clues in virus infections. Br Med J (1963) 0.79
pH stability studies with avian infectious bronchitis virus (coronavirus) strains. J Virol (1975) 0.79
GROWTH, PLAQUE PRODUCTION, AND CATIONIC STABILIZATION OF RHINOVIRUS TYPE 1 (ECHOVIRUS 28). J Bacteriol (1964) 0.77
COLDS AND THEIR VIRUSES. Br Med J (1964) 0.75
A study of porcine enteroviruses isolated from swine in the Toronto area. II. Characterization of the viruses as members of the picornavirus group. Can J Comp Med Vet Sci (1966) 0.75
Viruses and chronic bronchitis. Br Med J (1966) 0.75
The vacuolating virus, S.V. 40. Proc Soc Exp Biol Med (1960) 7.32
Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med (1954) 6.51
New antigenic variant in Far East influenza epidemic, 1957. Proc Soc Exp Biol Med (1957) 3.82
Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV-40. Proc Soc Exp Biol Med (1962) 3.32
TESTS IN HAMSTERS FOR ONCOGENIC QUALITY OF ORDINARY VIRUSES INCLUDING ADENOVIRUS TYPE 7. Proc Soc Exp Biol Med (1964) 3.15
Antigenic pattern of strains of influenza A and B. Proc Soc Exp Biol Med (1950) 2.70
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 2. Epidemiology and assessment of importance. N Engl J Med (1961) 2.66
Purification and characterization of chick embryo interferon. Proc Soc Exp Biol Med (1963) 2.57
The indirect complement fixation hemagglutination and conglutinating complement absorption tests for viruses of the psittacosis-lymphogranuloma venereum group. J Immunol (1951) 2.39
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 3. Clinical and laboratory findings. N Engl J Med (1961) 2.11
Distribution and significance of Asian and other influenza antibodies in the human population. N Engl J Med (1958) 1.97
Acute respiratory illnesses among children and adults. Field study of contemporary importance of several viruses and appraisal of the literature. JAMA (1962) 1.92
System for measuring and designating antigenic components of influenza viruses with analyses of recently isolated strains. Proc Soc Exp Biol Med (1951) 1.88
EFFECTIVE TREATMENT OF EXPERIMENTAL HERPES SIMPLEX KERATITIS WITH NEW DERIVATIVE, 5-METHYLAMINO-2'-DEOXYURIDINE (MADU). Proc Soc Exp Biol Med (1965) 1.84
Adenoviruses: group name proposed for new respiratory-tract viruses. Science (1956) 1.82
Influence of non-specific inhibitor on the diagnostic hemagglutination-inhibition test for influenza. J Immunol (1953) 1.81
Contributions to characterization and classification of animal viruses. Proc Soc Exp Biol Med (1963) 1.73
Laboratory studies on the 1950 outbreak of influenza. Public Health Rep (1950) 1.67
Recovery of new viruses (coryzavirus) from cases of common cold in human adults. Proc Soc Exp Biol Med (1961) 1.67
Use of living attenuated measles-virus vaccine in early infancy. N Engl J Med (1960) 1.62
Living attenuated measles-virus vaccine in early infancy. Studies of the role of passive antibody in immunization. N Engl J Med (1961) 1.60
Biophysical characterization of the RI (RI-67) viruses. Proc Soc Exp Biol Med (1955) 1.56
Epidemiology of RI(RI-67) group respiratory virus infections in recruit populations. Am J Hyg (1955) 1.47
Antibody response in volunteers to Asian influenza vaccine. J Am Med Assoc (1958) 1.45
Studies on the complement fixing antigens of poliomyelitis. I. Demonstration of type and group specific antigens in native and heated viral preparations. J Immunol (1958) 1.44
Search for virus in human malignancies. I. In vitro studies. Proc Soc Exp Biol Med (1962) 1.44
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 1. Laboratory findings in 109 cases. Proc Soc Exp Biol Med (1961) 1.43
Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine. Proc Soc Exp Biol Med (1956) 1.43
ATTEMPTS TO INTERRUPT VIRUS TUMORIGENESIS BY IMMUNIZATION USING HOMOLOGOUS "BJORKLUND-TYPE" ANTIGEN. Proc Soc Exp Biol Med (1963) 1.41
Elimination of nonspecific components from viral antigens by fluorocarbon. J Immunol (1958) 1.36
Epidemiologic investigations with respiratory disease virus RI-67. Am J Public Health Nations Health (1955) 1.34
Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. III. Evaluation of an SF-4 (shipping fever) virus vaccine in cattle. J Immunol (1961) 1.33
INTERRUPTION OF SV-40 VIRUS TUMORIGENESIS USING IRRADIATED HOMOLOGOUS TUMOR ANTIGEN. Proc Soc Exp Biol Med (1964) 1.32
Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin. N Engl J Med (1962) 1.31
NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. I. DEVELOPMENT AND ANIMAL IMMUNE RESPONSE. Proc Soc Exp Biol Med (1964) 1.30
Influenza antibodies in the population of the USA; an epidemiological investigation. Bull World Health Organ (1953) 1.30
Ender's live measles-virus vaccine with human immune globulin. II. Evaluation of efficacy. Am J Dis Child (1962) 1.25
Appraisal of occurrence of adenovirus-caused respiratory illness in military populations. Am J Hyg (1957) 1.24
A safe high-speed blendor for processing infectious materials. J Lab Clin Med (1958) 1.21
Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. I. Properties of the SF-4 (shipping fever) strain of virus. J Immunol (1961) 1.20
Preparation of dried antigen and antiserum for the agglutination-inhibition test for virus influenza. Public Health Rep (1951) 1.20
Factors influencing tumor induction in hamsters by vacuolating virus, SV. Proc Soc Exp Biol Med (1963) 1.20
Clinical and laboratory findings in cases of respiratory illness caused by coryzaviruses. Ann Intern Med (1962) 1.20
EPIDEMIOLOGIC INVESTIGATIONS OF RHINOVIRUS INFECTIONS. Proc Soc Exp Biol Med (1964) 1.19
ADDITIONAL RHINOVIRUS SEROTYPES. Proc Soc Exp Biol Med (1965) 1.19
Epidemiology of adenovirus respiratory infections in military recruit populations. Ann N Y Acad Sci (1957) 1.18
Effect of Westphal lipid A on viral activities in mice and hamsters. Proc Soc Exp Biol Med (1962) 1.15
Chemotherapy in bubonic lymphogranuloma venereum: a clinical and serological evaluation. Bull World Health Organ (1957) 1.11
Dissociation of poliomyelitis virus from neutralizing antibody. Virology (1958) 1.10
A guinea pig potency test for adenovirus vaccine. J Immunol (1960) 1.10
A pattern of antigen variation. Fed Proc (1952) 1.10
Comparison of the antigenic patterns of influenza A virus strains determined by in ovo neutralization and hemagglutination-inhibition. J Immunol (1952) 1.10
Electron microscopy of type 4 adenovirus strain R1-67. Virology (1957) 1.06
Antigenic relationships among adenoviruses with appraisal of reliability of complement-fixation test for typing isolates. J Immunol (1958) 1.04
A FORWARD LOOK AT VIRAL VACCINES: WITH SPECIAL REFERENCE TO A NEW IMMUNOLOGIC ADJUVANT. Am Rev Respir Dis (1964) 1.03
Clinical and laboratory studies in patients with respiratory disease caused by adenoviruses (RI-APC-ARD agents). Am J Med (1956) 1.03
Immunologic studies of measles. Am J Hyg (1961) 1.00
IMMUNOLOGIC, CHEMOTHERAPEUTIC AND INTERFERON APPROACHES TO CONTROL OF VIRAL DISEASE. Am J Med (1965) 0.98
In vivo and in vitro studies of serological specificity among viruses of the psittacosis-lymphogranuloma venereum group. J Immunol (1952) 0.98
Grouping and occurrence of RI (prototype RI-67) viruses. Proc Soc Exp Biol Med (1955) 0.97
A new viral agent associated with erythema infectiosum. Ann N Y Acad Sci (1957) 0.96
Studies of live attenuated measles virus vaccine in man. II. Appraisal of efficacy. Am J Public Health Nations Health (1962) 0.96
Immunogenic response to killed measles-virus vaccine. Studies in animals and evaluation of vaccine efficacy in an epidemic. Am J Dis Child (1962) 0.96
Enders' live measles-virus vaccine with human immune globulin. I. Clinical reactions. Am J Dis Child (1962) 0.95
CHARACTERIZATION OF CHICK EMBRYO INTERFERON INDUCED BY A DNA VIRUS. Proc Soc Exp Biol Med (1965) 0.94
Administration of Enders' live measles virus vaccine with human immune globulin. JAMA (1962) 0.94
Development of a purified poliomyelitis virus vaccine. JAMA (1961) 0.92
NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 2. SHORT-TERM ANIMAL TOXICITY TESTS. Proc Soc Exp Biol Med (1964) 0.91
RESPIRATORY SYNCYTIAL VIRUS. Am Rev Respir Dis (1963) 0.91
Pathogenicity and oncolytic capacity of RI virus strain RI-67 in man. J Lab Clin Med (1956) 0.91
NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 3. EFFICACY AND TOXICITY STUDIES IN MAN. N Engl J Med (1964) 0.91
Antigenic variation of influenza viruses. Annu Rev Microbiol (1954) 0.90
CLINICAL-EPIDEMIOLOGIC FINDINGS IN CORYZAVIRUS INFECTIONS. Am Rev Respir Dis (1963) 0.89
Group-specificity of psittacosis-lymphogranuloma venereum group skin test antigens in lymphogranuloma venereum patients. J Lab Clin Med (1958) 0.89
Efficacy of and indications for use of adenovirus vaccine. Am J Public Health Nations Health (1958) 0.88
FURTHER TESTS IN HAMSTERS FOR ONCOGENIC QUALITY OF ORDINARY VIRUSES AND MYCOPLASMA, WITH CORRELATIVE REVIEW. Proc Soc Exp Biol Med (1965) 0.87
Antibody response in volunteers to adenovirus vaccine and correlation of antibody with immunity. J Immunol (1958) 0.87
Respiratory viruses and respiratory virus vaccines. Am Rev Respir Dis (1963) 0.87
Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. II. Development and appraisal of potency of SF-4 (shipping fever) virus vaccine. J Immunol (1961) 0.87